News and features

In the last instalment of a three-part essay reflecting on five decades of cancer treatment advances, ICR CEO Professor Paul Workman explores the transition from classical chemotherapy drugs to new molecularly targeted treatments and immunotherapy, and discusses the attitudes and language used in the drive to defeat cancer.

Students from Wembley High Technology College visited The Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London, to learn how they could become the cancer researchers of the future.

Breast cancers which are particularly complex and diverse, as judged by a test used in ecology to analyse species of animals and plants, are particularly likely to progress and lead to death, a new study shows.

Scientists have developed a new viral therapy that is capable of killing prostate cancer cells, and found it is even more effective when combined with a type of radiotherapy.

Scientists have developed a mathematical model that describes a key step in human cell division – and an important target for cancer treatment – in unprecedented detail.

In a special, three-part essay, ICR Chief Executive Professor Paul Workman reflects on five decades of advances in cancer treatment – inspired by The Death of Cancer, an account by the clinical research pioneer Vincent DeVita. In part two, he explores the huge political repercussions of those early breakthroughs in treatment.

Research is enabling scientists to anticipate how different cancers evolve in the body, opening up the possibility of being able to predict how cancers change with time.

Researchers have identified a protein that controls how breast cancer cells spread around the body, according to a new study.

In a special, three-part essay to mark World Cancer Day, ICR Chief Executive Professor Paul Workman reflects on five decades of advances in cancer treatment – inspired by The Death of Cancer, an account by early pioneer Vincent DeVita. In part one, Professor Workman discusses the early days of chemotherapy.

On World Cancer Day, we wanted to recognise our many global collaborators who work with us to make the discoveries that defeat cancer.

A new global hub for cancer research and treatment is to be established in London with the aim of accelerating the discovery of new treatments.

The Institute of Cancer Research, London, has sold a portion of its royalty entitlement for the prostate cancer drug abiraterone for an undisclosed sum.